fincash logo SOLUTIONS

Fincash » Search » Aurobindo Pharma Ltd

Aurobindo Pharma Ltd

Updated on October 16, 2020

Stock/Share Code - AUROPHARMA

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 201903 Annual Report Page No: 147)

Below is the details of AUROPHARMA Aurobindo Pharma Ltd

Market Cap₹47,397 Cr.
Current Price ₹806.2 as on 21 Oct 20
52 Week High / Low Price₹967.6 / ₹281.15
Face Value₹1
Stock P/E21.00
Book Value₹222.3
Dividend Yield0.37 %
ROCE16.06 %
ROE15.38 %
Sales Growth (3yrs)11.36 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Cons: The company has delivered a poor growth of 10.46% over past five years. Dividend payout has been low at 9.01% of profits over last 3 years Company has high debtors of 159.29 days.

Aurobindo Pharma Ltd Price Chart

Aurobindo Pharma Ltd Price Chart

Aurobindo Pharma Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹169.4 28.81 ₹124,825.4 Cr. 0.77 -₹1,655.6 Cr. 24.82 -9.42 7585.25 10.53
2. Dr Reddy's Labs ₹5,046.75 36.47 ₹70,902.77 Cr. 0.59 ₹594.6 Cr. -12.11 14.73 4426.50 11.11
3. Cipla ₹767.1 34.95 ₹57,535.92 Cr. 0.42 ₹577.91 Cr. 20.85 8.95 4346.16 11.77
4. Aurobindo Pharma 21.00 ₹47,396.57 Cr. 0.37 ₹714.68 Cr. 116.24 11.07 3419.70 16.06
5. Biocon ₹439.6 70.21 ₹45,138 Cr. 0.13 ₹149.4 Cr. -27.58 14.56 1671.30 13.11
6. Torrent Pharma. ₹50.45 39.86 ₹45,039.6 Cr. 0.64 ₹321 Cr. 48.61 1.68 2056.00 15.01
7. Cadila Health. ₹426.35 26.88 ₹38,006.44 Cr. 0.94 ₹454 Cr. 49.54 4.11 3639.90 11.83
8. Alkem Lab ₹2,650.8 23.87 ₹32,553.96 Cr. 0.92 ₹422.01 Cr. 127.54 8.33 2003.49 18.58

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Aurobindo Pharma Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -3,0742,6862,3552,5593,1703,2483,2813,0793,2223,3463,6203,420
YOY Sales Growth %27.54%6.54%-2.70%16.93%3.14%20.91%39.32%20.32%1.62%3.00%10.36%11.07%
Expenses -2,0352,0221,8772,1622,5632,6502,5462,5282,5902,6942,7722,455
Material Cost %39.83%46.69%46.77%51.48%50.63%51.89%47.91%50.09%50.46%50.50%46.03%41.40%
Employee Cost %8.83%10.54%13.48%12.48%10.47%10.77%11.03%12.26%11.61%11.50%11.74%12.42%
Operating Profit1,039664478397607598734550631651849965
OPM %34%25%20%16%19%18%22%18%20%19%23%28%
Other Income293463413728303438161126
Profit before tax966595375282479585618433522549873960
Tax %22%25%18%20%21%21%26%24%24%24%17%26%
Net Profit753444308225381464460330398419725715
EPS in Rs12.857.585.263.846.507.917.855.646.807.1512.3712.20

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -2,7493,1954,1304,2775,4247,1088,0699,1589,60710,27012,25813,26613,607
Sales Growth %20.80%16.23%29.24%3.57%26.81%31.06%13.51%13.50%4.91%6.90%19.36%8.23%
Expenses -2,5002,4973,1733,7044,4665,1875,8166,7057,2157,6009,83810,57810,512
Material Cost %59.00%54.76%53.29%58.89%55.51%49.01%46.81%46.85%48.37%44.43%50.41%49.17%
Manufacturing Cost %9.91%9.97%10.34%11.42%11.06%9.37%9.69%9.80%9.83%10.35%10.61%9.99%
Employee Cost %6.45%7.28%7.35%8.51%7.96%7.24%8.29%8.82%9.65%11.02%11.12%11.77%
Other Cost %15.56%6.15%5.84%7.78%7.81%7.36%7.29%7.75%7.25%8.20%8.11%8.80%
Operating Profit2506989575739581,9222,2532,4532,3922,6702,4202,6883,096
OPM %9%22%23%13%18%27%28%27%25%26%20%20%23%
Other Income7517229-30027736518711881189401358
Profit before tax161712805-1385631,5191,9402,1482,1792,3431,9652,3782,904
Tax %20%26%26%69%12%23%22%24%22%23%22%21%
Net Profit129526594-434961,1721,5161,6271,7071,8131,5301,8732,257
EPS in Rs2.329.352.010.008.4019.8525.5327.8028.7330.9426.1131.9638.52
Dividend Payout %19%5%10%-68%9%7%9%9%9%8%10%9%

Compounded Sales Growth

  • 10 Years:: 15.30%
  • 5 Years:: 10.46%
  • 3 Years:: 11.36%
  • TTM:: 6.49%

Compounded Profit Growth

  • 10 Years:: 13.74%
  • 5 Years:: 4.31%
  • 3 Years:: 2.91%
  • TTM:: 38.03%

Return on Equity

  • 10 Years:: 22.71%
  • 5 Years:: 1.94%
  • 3 Years:: 2.17%
  • 1 Year:: 34.69%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -272829292929295959595959
Equity Capital272829292929295959595959
Other Liabilities -5997359547041,1031,6381,5821,5341,5332,0922,2702,768
Trade Payables4155147335859011,2361,1461,2791,2181,6291,8411,915
Advance from Customers3351261494576617
Other liability items181185209113188393431250308457423836
Total Liabilities4,0344,5945,8415,9916,8258,57610,22612,56613,02315,79418,14119,535
Fixed Assets -8731,0451,3501,6272,0121,9382,1902,5683,2123,3934,1504,365
Gross Block1,2621,5271,9552,3632,9073,0093,5082,8313,7584,2925,4466,115
Accumulated Depreciation3894826057378961,0711,3182635478991,2961,750
Other Assets -2,6062,6783,4613,1773,9385,5616,7968,0727,2229,28910,86311,924
Trade receivables1,1061,1511,4801,4261,7312,9703,7094,3813,7744,4685,2325,790
Cash Equivalents875122141151011331342467678
Loans n Advances6975944195044974085128999961,2401,5691,465
Other asset items-19-161791316546141929-14-7415276
Total Assets4,0344,5945,8415,9916,8258,57610,22612,56613,02315,79418,14119,535

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -53462455046253285902,4579225302,162
Profit from operations3827379785179561,9352,3162,4822,6722,4242,774
Loans Advances-45-68-8685-8-44-92-12-2-3
Other WC items00-12-391-3-4-110-126-19851
Working capital changes-338-244-55615-215-1,268-1,300457-1,220-1,412-234
Direct taxes-39-148-177-28-116-339-426-482-530-482-379
Cash from Investing Activity --302-408-569-534-295-401-624-1,542-991-1,301-919
Fixed assets purchased-289-342-516-401-166-149-544-1,020-976-890-655
Fixed assets sold1183121022256355
Investments purchased-69-73-200-15300-198-541-257-358-181
Investments sold480390230029000
Interest received172465341742211
Dividends received00000000079129
Invest in subsidiaries0000-137-24900000
Loans to subsidiaries-10-3800-8-21-30000
Inter corporate deposits000000-10000
Other investing items0310015-133102-16-15-136-278
Cash from Financing Activity -161-14443-78-229-3135-1,329440599-1,252
Proceeds from shares05101377000
Redemption of debentures-140-6-10-9410000000
Proceeds from borrowings4441806221,11328710137809919520
Repayment of borrowings-48-108-90-149-352-7-110-1,157-238-65-970
Interest paid fin-55-56-33-68-98-70-59-42-49-127-88
Dividends paid-39-29-47-34-67-60-153-114-219-146-176
Financial liabilities0000000000-9
Other financing items000000-28-23-45-14-10
Net Cash Flow-136-75118-108101-1051-414371-171-9

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %7%21%20%9%15%29%27%24%20%19%15%16%
Debtor Days147132131122116153168175143159156159
Inventory Turnover2.512.

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Aurobindo Pharma Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.